According to Future Market Insights, the global post-operative cataract surgery inflammation treatment industry growth is projected to rise at a steady growth valued at US$ 4.56 billion 2023 with a 6.77% CAGR until 2033, being valued at US$ 8.78 billion. The rising number of cortical necrosis therapeutics are being delivered through retail pharmacies and the …